GenLight Technologies Personalized Genomics Medicine

GenLight Technologies Personalized Genomics Medicine Personalized genomics-guided precision medicine for therapy-resistant prostate and breast cancers (h Long-term genomics-guided health management.

Genomics-guided personalized disease prevention, target-tailored precision medicine (http://genlighttechnology.com). Personalized genomics-guided precision medicine for therapy-resistant prostate and breast cancers (http://genlighttechnology.com). Inflammation & autoimmune disorders. Prostate, breast, and colon cancer risk assessment, diagnostic, prognostic, and therapy-selection services (http://genlighttechnology.com). Genlighttechnology provides unique, proprietary approach to consulting, diagnostics, and therapy-selection disease management and health maintenance services for individuals diagnosed with prostate & breast cancers. We provide these services to assist practicing physicians and cancer patients in decision-making process at the time of diagnosis of tumors in the prostate when the critical decision is made to select active surveillance ("watchful waiting") or aggressive therapeutic interventions with curative intent such as radical prostatectomy. Here is how it works.

1. You are diagnosed with prostate cancer. We will help to make a choice what treatment options to select. For many patients, it may be possible to determine before the treatment how likely is that initial therapy may fail and how soon cancer may come back after the treatment. This information will help to make a decision whether the individual patients are more or less likely to benefit from immediate or near-term therapeutic interventions. This is important because:

i) Treatment of prostate cancer is often associated with complications which significantly affect the quality of life of patients. These complications will adversely affect patients’ life to a greater extent than disease itself. ii) Most patients diagnosed with the early-stage prostate cancer will have clinically indolent disease. They typically have no clinical symptoms and disease will have no adverse effects of their well-being and quality of life. Therefore, these patients do not need immediate aggressive treatment because there will be no significant survival benefits from the treatment during their lifetime.

2. You already received treatment for prostate cancer. Your disease is in remission or you are “cancer-free”. For many patients, after the initial therapy was administered and they are "cancer-free'” with no clinical evidence of disease, we may be able help to determine the likelihood of therapy failure and disease relapse in the future. We may be able to determine how likely is that cancer may come back because patients have clinically latent residual disease and how soon it may progress to clinically lethal metastatic cancer. This is important because as early detection of primary tumors helps to increase the likelihood of cure, early detection of clinically latent residual disease may help to prevent the disease progression to metastatic, late-stage, lethal disease with no significant prospect of cure or choices of effective treatment options. We hope that this knowledge will help you, your family, and your doctors to make rational, evidence-based decisions on what steps to take and how to manage your life after being diagnosed with cancer.

Glinsky, G.V. Transposable Elements Seed Transcription Factor Binding Sites to Sequence-Specific Double-Stranded DNA Bin...
11/19/2025

Glinsky, G.V. Transposable Elements Seed Transcription Factor Binding Sites to Sequence-Specific Double-Stranded DNA Binding TF Networks Contributing to Governance of Primate Brain Evolution. J Mol Evol (2025).

Transposable elements (TEs) have played a pivotal role in shaping the regulatory architecture of mammalian genomes. This contribution reports multiple lines of evidence suggesting that TE have made a significant impact on brain development by providing sequences for thousands of transcription factor...

06/15/2025

Genome-wide, chromosome-naïve compartmentalization of major developmental networks tailored by modular placement of human embryo-regulatory Long Terminal Repeats
Gennadi V. Glinsky
Academia Molecular Biology and Genomics
2(2)
Section: Computational Genomics and Bioinformatics

06/14/2025

Genome-wide, chromosome-naïve compartmentalization of major developmental networks tailored by modular placement of human embryo-regulatory Long Terminal Repeats.

Just published in Academia Molecular Biology and Genomics!
academia.edu/3064-9765/2/2/…
with Gennadi V. Glinsky

Timelines of population-level effects of viruses on humans varied from the evolutionary scale of million years to contem...
09/19/2022

Timelines of population-level effects of viruses on humans varied from the evolutionary scale of million years to contemporary spread of viral infections. Correspondingly, these events are exemplified by: (i) emergence of human endogenous retroviruses (HERVs) from ancient germline infections leading to stable integration of viral genomes into human chromosomes; and (ii) wide-spread viral infections reaching a global pandemic state such as the COVID-19 pandemic. Despite significant efforts, understanding of HERV's roles in governance of genomic regulatory networks, their impacts on primate evolution and development of human-specific physiological and pathological phenotypic traits remains limited. Remarkably, present analyses revealed that expression of a dominant majority of genes (1696 of 1944 genes; 87%) constituting high-confidence down-steam regulatory targets of defined HERV loci was significantly altered in cells infected with the SARS-CoV-2 coronavirus, a pathogen causing the global COVID-19 pandemic. This study focused on defined sub-sets of DNA sequences derived from HERVs that are expressed at specific stages of human preimplantation embryogenesis and exert regulatory actions essential for self-renewal and pluripotency. Evolutionary histories of LTR7/HERVH and LTR5_Hs/HERVK were charted based on evidence of the earliest presence and expansion of highly conserved (HC) LTR sequences. Sequence conservation analyses of most recent releases 17 primate species' genomes revealed that LTR7/HERVH have entered germlines of primates in Africa after the separation of the New World Monkey lineage, while LTR5_Hs/HERVK successfully colonized primates' germlines after the segregation of Gibbons' species. Subsequently, both LTR7 and LTR5_Hs undergo a marked ~ fourfold-fivefold expansion in genomes of Great Apes. Timelines of quantitative expansion of both LTR7 and LTR5_Hs loci during evolution of Great Apes appear to replicate the consensus evolutionary sequence of increasing cognitive and behavioral complexities of non-human primates, which seems particularly striking for LTR7 loci and 11 distinct LTR7 subfamilies. Consistent with previous reports, identified in this study, 351 human-specific (HS) insertions of LTR7 (175 loci) and LTR5_Hs (176 loci) regulatory sequences have been linked to genes implicated in establishment and maintenance of naïve and primed pluripotent states and preimplantation embryogenesis phenotypes. Unexpectedly, HS-LTRs manifest regulatory connectivity to genes encoding markers of 12 distinct cells' populations of fetal go**ds, as well as genes implicated in physiology and pathology of human spermatogenesis, including Y-linked spermatogenic failure, oligo- and azoospermia. Granular interrogations of genes linked with 11 distinct LTR7 subfamilies revealed that mammalian offspring survival (MOS) genes seem to remain one of consistent regulatory targets throughout ~ 30 MYA of the divergent evolution of LTR7 loci. Differential GSEA of MOS versus non-MOS genes identified clearly discernable dominant enrichment patterns of phenotypic traits affected by MOS genes linked with LTR7 (562 MOS genes) and LTR5_Hs (126 MOS genes) regulatory loci across the large panel of genomics and proteomics databases reflecting a broad spectrum of human physiological and pathological traits. GSEA of LTR7-linked MOS genes identified more than 2200 significantly enriched records of human common and rare diseases and gene signatures of 466 significantly enriched records of Human Phenotype Ontology traits, including Autosomal Dominant (92 genes) and Autosomal Recessive (93 genes) Inheritance. LTR7 regulatory elements appear linked with genes implicated in functional and morphological features of central nervous system, including synaptic transmission and protein-protein interactions at synapses, as well as gene signatures differentially regulated in cells of distinct neurodevelopmental stages and morphologically diverse cell types residing and functioning in human brain. These include Neural Stem/Precursor cells, Radial Glia cells, Bergman Glia cells, Pyramidal cells, Tanycytes, Immature neurons, Interneurons, Trigeminal neurons, GABAergic neurons, and Glutamatergic neurons. GSEA of LTR7-linked genes identified significantly enriched gene sets encoding markers of more than 80 specialized types of neurons and markers of 521 human brain regions, most prominently, subiculum and dentate gyrus. Identification and characterization of 1944 genes comprising high-confidence down-steam regulatory targets of LTR7 and/or LTR5_Hs loci validated and extended these observations by documenting marked enrichments for genes implicated in neoplasm metastasis, intellectual disability, autism, multiple cancer types, Alzheimer's, schizophrenia, and other brain disorders. Overall, genes representing down-stream regulatory targets of ancient retroviral LTRs exert the apparently cooperative and exceedingly broad phenotypic impacts on human physiology and pathology. This is exemplified by altered expression of 93% high-confidence LTR targets in cells infected by contemporary viruses, revealing a convergence of virus-inflicted aberrations on genomic regulatory circuitry governed by ancient retroviral LTR elements and interference with human cells' differentiation programs.

Timelines of population-level effects of viruses on humans varied from the evolutionary scale of million years to contemporary spread of viral infections. Correspondingly, these events are exemplified by: (i) emergence of human endogenous retroviruses (HERVs) from ancient germline infections leading...

Remarkable progress in understanding genomics and epigenetics of stemness pathways highlights novel therapeutic targets ...
05/28/2021

Remarkable progress in understanding genomics and epigenetics of stemness pathways highlights novel therapeutic targets for undruggable clinically lethal cancers and human brain disorders

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Activation of regulatory DNA sequences derived from certain Human Endogenous Retroviruses (HERV) plays a key role in dev...
05/28/2021

Activation of regulatory DNA sequences derived from certain Human Endogenous Retroviruses (HERV) plays a key role in development of neurodegenerative, neurodevelopmental, & neuropsychiatric disorders

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Sustained activity of regulatory DNA sequences derived from certain Human Endogenous Retroviruses (HERV) plays a key rol...
05/28/2021

Sustained activity of regulatory DNA sequences derived from certain Human Endogenous Retroviruses (HERV) plays a key role in development of therapy resistant clinically lethal cancers

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Activation of regulatory DNA sequences derived from certain Human Endogenous Retroviruses (HERV) plays a key role in a p...
05/28/2021

Activation of regulatory DNA sequences derived from certain Human Endogenous Retroviruses (HERV) plays a key role in a persisten failure of the homeostatic cycle of replenishment dying differentiated cells in human body.

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

In contrast to mutations-initiated/mutations-accumulating slowly progressing tumors, failures of epigenetic silencing of...
05/28/2021

In contrast to mutations-initiated/mutations-accumulating slowly progressing tumors, failures of epigenetic silencing of specific endogenous retroviral loci play a key role in development of therapy resistant clinically lethal cancers

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Intrinsic propensity of stem cell like cancers to spread from the very early stages of tumor initiation and progression ...
05/28/2021

Intrinsic propensity of stem cell like cancers to spread from the very early stages of tumor initiation and progression contributes to therapy resistance even if detected at the early stages. Cure of stem cell like cancers requires novel therapies.

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Stem cell like cancer cells are epigenetically wired to survive in blood & lymph, travel throughout the body, spread and...
05/28/2021

Stem cell like cancer cells are epigenetically wired to survive in blood & lymph, travel throughout the body, spread and seed metastatic tumors at distant organs. Treatment would require epigenetic interference & chromatin silencing recovery tools.

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Humans have 2 distinct types of cancers: 1.Curable if detected early mutations-accumulating slowly progressing tumors; 2...
05/28/2021

Humans have 2 distinct types of cancers: 1.Curable if detected early mutations-accumulating slowly progressing tumors; 2.Therapy resistant clinically lethal stem cell like cancers due to loss of epigenetic silencing of specific retroviral loci.

Repetitive DNA sequences (repeats) colonized two-third of human genome and a majority of repeats comprised of transposable genetic elements (TE). Evolutionary distinct categories of TE represent nucleic acid sequences that are repeatedly copied from and pasted into chromosomes at multiple genomic lo...

Address

San Diego, CA
92037

Alerts

Be the first to know and let us send you an email when GenLight Technologies Personalized Genomics Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to GenLight Technologies Personalized Genomics Medicine:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram